Coronary artery disease genetics: Bigger is better

European Heart Journal

Volumn 25, Issue 11, 2004, Pages 900-901

  Channon, Keith M ^a   Watkins, Hugh ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 37; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; STROMELYSIN;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; DISEASE PREDISPOSITION; EDITORIAL; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC RISK; HEART INFARCTION; HUMAN; LIPID METABOLISM; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CORONARY VASOSPASM; FEMALE; HUMANS; MALE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 3042790815     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.04.013     Document Type: Editorial

References (10)

1. Murase Y, Yamada Y, Hirashiki A, et al. Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. Eur Heart J; 25:970-977
2. Guzik T.J., West N.E.J., Black E., et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox subunit on vascular superoxide production in atherosclerosis. Circulation. 102:2000;1744-1747
3. Li A., Prasad A., Mincemoyer R., et al. Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function. Am. J. Med. Genet. 86:1999;57-61
4. Schachinger V., Britten M.B., Dimmeler S., et al. NADH/NADPH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function. Eur. Heart. J. 22:2001;96-101
5. Keavney B., McKenzie C., Parish S., et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet. 355:2000;434-442
6. Wheeler J.G., Keavney B.D., Watkins H., et al. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet. 363:2004;689-695
7. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N. Engl. J. Med. 347:2002;1916-1923
8. Broeckel U., Hengstenberg C., Mayer B., et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat. Genet. 30:2002;210-214
9. Ozaki K., Ohnishi Y., Iida A., et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat. Genet. 32:2002;650-654
10. The PROCARDIS Consortium. A trio family study showing association of the lymphotoxin-alpha N26 (804A) allele with coronary artery disease. Eur J Hum Genet [in press]